Colorectal Cancer: Open Access

Market Analysis – Europe

The global breast cancer therapy market is expected to register a CAGR of 8.5% during the forecast period 2018- 2023. The high incidence rate of breast cancer is now becoming a concern, and several pharmaceutical companies are increasingly investing in research on breast cancer. Thus, the market is expected to grow. Statistics say that around 50% of breast cancer cases and more than 58% of deaths occur in less developed countries. The National Cancer Institute has estimated that 246,660 cases of breast cancer were diagnosed in 2016. The high incidence and prevalence rate show that the breast cancer therapeutics market will boost over the forecast period. Today, an increasing number of countries are adopting early cancer detection programs, around the world. If these initiatives continue, the demand for breast cancer therapeutics is bound to increase, with most of the cases being detected in the early stages. Along with the other factors, such as high investments on R&D, and the advancements in cancer biology and pharmacology promoting drug development, are driving the market. North America dominates the market for breast cancer therapy, due to the fact that the prevalence of breast cancer is on the rise in this region, along with an increase in R&D funding through public and private sectors. Asia- Pacific region is expected to grow at a significant pace, over the forecast period.

Target Audience

• Cancer Biologists

• Oncologists

• Residents

• Pathologists

• Nurses

• Directors/Managers

• Medical Devices Companies

Importance & Scope:

Breast Pathology 2020 deals with Breast Pathology & cancer knowledge and characteristics, Screening, Detecting and Diagnosing Breast Cancer, Breast cancer therapy, Cancer research, prevention and medicine, Surgery Choices for Breast Cancer, Personalized Medicine, Clinical trials of Breast Cancer, Male Breast Cancer and Breast cancer Nursing. Breast cancer is the main type of cancer from which most of the women are suffering worldwide. Awareness about the breast cancer risks, symptoms and treatment is very important. Introduction of new techniques in the field of medicine as well as diagnosis is going on worldwide. Breast Pathology Conference 2020 provide a platform for sharing of information about the breast cancer treatment techniques and newly developed techniques for the same as well as provide platform about the recent researches on breast cancer. This event includes prompt keynote presentations, oral talks, poster presentations and exhibitions.

Top Universities around the World:

• University of Valencia, Spain

• University of Hong Kong, Hong Kong

• Yale School of Medicine, USA

• National Center for Tumor Diseases (NCT), Germany

• Vall D'Hebron Institute of Oncology, Spain

• Breast Center, Holweide Hospital, Germany.

• International Agency for Research on Cancer, France

• National Cancer Institute, Cairo University, Egypt

• Spanish National Cancer Research Center, Madrid, Spain

• National Cancer Institute, Bethesda, USA

• Hospital Universitario La Paz, Madrid, Spain

• Georg-August University, Gottingen, Germany

• Hacettepe University Institute of Oncology, Turkey

• National University of Singapore, Singapore

Top Societies and Association around the World:

• Breast Screen Australia Program, Australia

• Asociación Española Contra el Cáncer, Madrid, Spain

• Cancer Society of Finland, Finland

• Association of Parents of Children with Cancer, Madrid, Spain

• Cancer Society of New Zealand, New Zealand

• Japanese Breast Cancer Society, Japan

• Instituto Madrileño de Oncología, FondacionGrupo (IMO), Spain

• International Agency for Research on Cancer, France

• National Cancer Institute, Cairo University, Cairo, Egypt

• Society of Oncology Nursing, Madrid, Spain

• National Cancer Institute, USA

• Hacettepe University Institute of Oncology, Turkey

• National University of Singapore, Singapore

Global Market for Breast Cancer Drugs :

The global market for breast cancer drugs is growing steadily due to rising patient population, introduction of new drugs and sales growth of Perjeta and Kadcyla. The latest biotechnology market report from Trend Force states that the global market scale of breast cancer drugs reached US$11.97 billion in 2016 and is forecast to expand at a CAGR of 9.3% to US$22.35 billion in 2023.

Based on the surface antigens of tumor cells, breast cancers are classified into three subtypes – HER2-positive, HR-positive and triple-negative. The market for drugs treating HER2-positive breast cancers has been growing rapidly, driven by the growing sales of Kadcyla and Perjeta worldwide. The global market scale of HER2-positive drugs was around US$7.41 billion in 2016, and Trend Force projects that it will arrive at U$12.42 billion in 2023 with the CAGR during the 2016~2023 period at about 7.7%.Likewise, the market for HR-positive and triplenegative breast cancer drugs will keep booming over the next several years as sales of Ibrance are expected to remain robust and new drugs such as CDK4/6 inhibitors enter the market. According to Trend Force’s analysis, the global market scale of HR-positive and triple-negative breast cancer drugs came to US$4.56 billion in 2016 and is going to expand at a CAGR of 11.8% to reach US$9.93 billion in 2023.

References:

https://www.cancer.gov/types/breast/research

http://www.breastcancerresearch.ie/

https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-015-0184-3

Why attend Euro Breast pathology Summit 2020?

World Congress on Breast pathology & Cancer diagnosis, held during July 27-28, 2020, Webinar. We are happy to invite all anticipated participants to share and explore their research findings as keynote presentations, Oral talks, Poster presentations, Workshops and Exhibitions. About half of the deaths from all over the world are due to Breast Cancer the impact of super bugs challenges human race with unpredictable epidemics, outbreaks that took major rank in deaths and economical damage. World Congress on Breast Cancer is going to be platform for the concern people around world on Breast diseases. It aims to expose current and future trends, new techniques, epidemiology’s among peers, speakers, learning space for young researchers, and workshops. Euro Breast pathology meeting 2020 will be organized with theme “Early detection is the minimal way.”